Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination.

Tefit JN, Crabé S, Orlandini B, Nell H, Bendelac A, Deng S, Savage PB, Teyton L, Serra V. Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination. Vaccine. 2014 Oct 21; 32(46):6138-45.

View in: PubMed

collapse authors with profiles